Oryza Pharmaceuticals Inc.
18 drugs in NADAC|18 Generic,0 Brand
Oryza Pharmaceuticals Inc. lists 18 NDCs in the CMS NADAC file (18 generic, 0 brand), at an average NADAC of $0.14 per unit, with a week-over-week move of +1.6% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
18
18G / 0B
Avg Price / Unit
$0.1363
$0.06 – $0.30
Avg 7d Change
+1.65%
Across 18 drugs with changes
7d Activity
of 18 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Oryza Pharmaceuticals Inc. make?
Oryza Pharmaceuticals Inc. lists 18 NDCs in the CMS NADAC file — 18 generic and 0 brand products.
What is the average price of Oryza Pharmaceuticals Inc. drugs?
The average NADAC across Oryza Pharmaceuticals Inc.'s portfolio is $0.1363 per unit, ranging from $0.0555 to $0.3048.
What types of drugs does Oryza Pharmaceuticals Inc. make?
Oryza Pharmaceuticals Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Central Nervous System Stimulant (20), beta-Adrenergic Blocker (13).
Has Oryza Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Oryza Pharmaceuticals Inc. in the openFDA feed.
How has Oryza Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 9 Oryza Pharmaceuticals Inc. products rose and 9 fell, with a portfolio-wide average change of +1.6%.